• 1
    Manikandan R, Kumar S, Dorairajan LN. Hemorrhagic cystitis: a challenge to the urologist. Indian J Urol 2010; 26: 159166
  • 2
    Hassan Z. Management of refractory hemorrhagic cystitis following hematopoietic stem cell transplantation in children. Pediatr Transplant 2011; 15: 348361
  • 3
    Bassi PF, Costantini E, Foley S, Palea S. Glycosaminoglycan therapy for bladder diseases: emerging new treatments. Eur Urol Suppl 2011; 10: 451459
  • 4
    Mukhtar S, Woodhouse C. The management of cyclophosphamide-induced haematuria. BJU Int 2010; 105: 908912
  • 5
    Decker DB, Karam JA, Wilcox DT. Pediatric hemorrhagic cystitis. J Pediatr Urol 2009; 5: 254264
  • 6
    Cancer Research UK. World cancer factsheet. Available at: Accessed September 2012
  • 7
    Miodosky M, Abdul-Hai A, Tsirigotis P et al. Treatment of post-hematopoietic stem cell transplantation hemorrhagic cystitis with intravesicular sodium hyaluronate. Bone Marrow Transplant 2006; 38: 507511
  • 8
    El-Zimaity M, Saliba R, Chan K et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters. Blood 2004; 103: 46744680
  • 9
    Droller MJ, Saral R, Santos G. Prevention of cyclophosphamide-induced hemorrhagic cystitis. Urology 1982; 20: 256258
  • 10
    Garderet L, Bittencourt H, Sebe P et al. Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients. Transplantation 2000; 70: 18071811
  • 11
    Russell SJ, Vowels MR, Vale T. Haemorrhagic cystitis in paediatric bone marrow transplant patients: an association with infective agents, GVHD and prior cyclophosphamide. Bone Marrow Transplant 1994; 13: 533539
  • 12
    Sandoval C, Swift M. Treatment of lymphoid malignancies in patients with ataxia-telangiectasia. Med Pediatr Oncol 1998; 31: 491497
  • 13
    Le Guenno G, Mahr A, Pagnoux C, Dhote R, Guillevin L, French Vasculitis Study Group. Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with systemic necrotizing vasculitides. Arthritis Rheum 2011; 63: 14351445
  • 14
    Klatersky J. Side effects of ifosfamide. Oncology 2003; 65 (Suppl. 2): 710
  • 15
    Lima MV, Ferreira FV, Macedo FY, de Castro Brito GA, Ribeiro RA. Histological changes in bladders of patients submitted to ifosfamide chemotherapy even with mesna prophylaxis. Cancer Chemother Pharmacol 2007; 59: 643650
  • 16
    Korkmaz A, Topal T, Oter S. Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation. Cell Biol Toxicol 2007; 23: 303312
  • 17
    Emadi A, Jones RJ, Brodsky RA. Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol 2009; 6: 638647
  • 18
    Xu LP, Zhang HY, Huang XJ et al. Hemorrhagic cystitis following hematopoietic stem cell transplantation: incidence, risk factors and association with CMV reactivation and graft-versus-host disease. Chin Med J (Engl) 2007; 120: 16661671
  • 19
    Tsuboi K, Kishi K, Ohmachi K et al. Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation. Bone Marrow Transplant 2003; 32: 903907
  • 20
    Tang W, Wang L, Zhao WL, Chen YB, Shen ZX, Hu J. Intravenous busulfan-cyclophosphamide as a preparative regimen before allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia. Biol Blood Marrow Transplant 2011; 17: 15551561
  • 21
    Carpenter PA, Marshall GM, Giri N, Vowels MR, Russell SJ. Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia conditioned with busulfan, cyclophosphamide and melphalan. Bone Marrow Transplant 1996; 18: 489494
  • 22
    NCI. Common terminology criteria for adverse events, v3.0 (CTCAE), 2003. Available at: Accessed June 2013
  • 23
    Hassan Z, Remberger M, Svenberg P et al. Hemorrhagic cystitis: a retrospective single-center survey. Clin Transplant 2007; 21: 659667
  • 24
    Shi-Xia X, Xian-Hua T, Hai-Qin X, Bo F, Xiang-Feng T. Total body irradiation plus cyclophosphamide versus busulphan with cyclophosphamide as conditioning regimen for patients with leukemia undergoing allogeneic stem cell transplantation: a meta-analysis. Leuk Lymphoma 2010; 51: 5060
  • 25
    Ringdén O, Labopin M, Tura S et al. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 1996; 93: 637645
  • 26
    Ringdén O, Ruutu T, Remberger M et al. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group. Blood 1994; 83: 27232730
  • 27
    Sencer SF, Haake RJ, Weisdorf DJ. Hemorrhagic cystitis after bone marrow transplantation. Risk factors and complications. Transplantation 1993; 56: 875879
  • 28
    Lazzeri M, Montorsi F. The therapeutic challenge of ‘chronic cystitis’: search well, work together, and gain results. Eur Urol 2011; 60: 7880
  • 29
    Lamm D, Persad R, Colombel M, Brausi M. Maintainance Bacillus Calmette-Guérin: the standard of care for the prophylaxis and management of intermediate- and high-risk non-muscle-invasive bladder cancer. Eur Urol Suppl 2010; 9: 715734
  • 30
    Hall MC, Chang SS, Dalbagni G et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 2007; 178: 23142330
  • 31
    Soloway MS, Hepps D, Katkoori D, Ayyathurai R, Manoharan M. Radical cystectomy for BCG failure: has the timing improved in recent years? BJU Int 2011; 108: 182185
  • 32
    Isaka S, Okano T, Abe K, Shimazaki J. Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder cancer. Cancer Chemother Pharmacol 1992; 30 (Suppl.): S4144
  • 33
    Witjes JA, Caris CT, Mungan NA, Debruyne FM, Witjes WP. Results of a randomized phase III trial of sequential intravesical therapy with mitomycin C and bacillus Calmette-Guerin versus mitomycin C alone in patients with superficial bladder cancer. J Urol 1998; 160: 16681671
  • 34
    Crawford ML, Waller PC, Wood SM. Severe cystitis associated with tiaprofenic acid. Br J Urol 1997; 79: 578584
  • 35
    Buchbinder R, Forbes A, Kobben F, Boyd I, Snow RM, McNeil JJ. Clinical features of tiaprofenic acid (surgam) associated cystitis and a study of risk factors for its development. J Clin Epidemiol 2000; 53: 10131019
  • 36
    Kim SJ, Koh DH, Park JS, Ahn HS, Choi JB, Kim YS. Hemorrhagic cystitis due to intravesical instillation of gentian violet completely recovered with conservative therapy. Yonsei Med J 2003; 44: 163165
  • 37
    Chen CH, Lee MH, Chen YC, Lin MF. Ketamine-snorting associated cystitis. J Formos Med Assoc 2011; 110: 787791
  • 38
    Folland DS, Kimbrough RD, Cline RE, Swiggart RC, Schaffner W. Acute hemorrhagic cystitis. Industrial exposure to the pesticide chlordimeform. JAMA 1978; 239: 10521055
  • 39
    Sandhu SS, Goldstraw M, Woodhouse CR. The management of haemorrhagic cystitis with sodium pentosan polysulphate. BJU Int 2004; 94: 845847
  • 40
    Denton AS, Clarke N, Maher J. Non-surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvis. Cochrane Database Syst Rev 2002; (3)CD001773
  • 41
    Vilar DG, Fadrique GG, Martín IJ et al. Hyperbaric oxygen therapy for the management of hemorrhagic radio-induced cystitis. Arch Esp Urol 2011; 64: 869874
  • 42
    James ND, Hussain SA, Hall E et al. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med 2012; 366: 14771488
  • 43
    Smit SG, Heyns CF. Management of radiation cystitis. Nat Rev Urol 2010; 7: 206214
  • 44
    Hadjibabaie M, Alimoghaddam K, Shamshiri AR et al. Continuous bladder irrigation prevents hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. Urol Oncol 2008; 26: 4346
  • 45
    Turkeri LN, Lum LG, Uberti JP et al. Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation. J Urol 1995; 153: 637640
  • 46
    Rosenzweig MQ, Schaefer PM, Rosenfeld CS. Prevention of transplant-related hemorrhagic cystitis using bladder irrigation with sorbitol. Bone Marrow Transplant 1994; 14: 491492
  • 47
    Meisenberg B, Lassiter M, Hussein A, Ross M, Vredenburgh JJ, Peters WP. Prevention of hemorrhagic cystitis after high-dose alkylating agent chemotherapy and autologous bone marrow support. Bone Marrow Transplant 1994; 14: 287291
  • 48
    Atkinson K, Biggs JC, Golovsky D et al. Bladder irrigation does not prevent haemorrhagic cystitis in bone marrow transplant recipients. Bone Marrow Transplant 1991; 7: 351354
  • 49
    Trotman J, Nivison-Smith I, Dodds A. Haemorrhagic cystitis: incidence and risk factors in a transplant population using hyperhydration. Bone Marrow Transplant 1999; 23: 797801
  • 50
    Murphy C, Harden E, Stevens D, Lynch J, Montes V, Herzig R. The addition of mesna to hyperhydration does not decrease the incidence of hemorrhagic cystitis in patients receiving high-dose cyclophosphamide. Oncol Rep 1994; 1: 265266
  • 51
    Shepherd JD, Pringle LE, Barnett MJ, Klingemann HG, Reece DE, Phillips GL. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation. J Clin Oncol 1991; 9: 20162020
  • 52
    Vose JM, Reed EC, Pippert GC et al. Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial. J Clin Oncol 1993; 11: 13061310
  • 53
    Katz A, Epelman S, Anelli A et al. A prospective randomized evaluation of three schedules of mesna administration in patients receiving an ifosfamide-containing chemotherapy regimen: sustained efficiency and simplified administration. J Cancer Res Clin Oncol 1995; 121: 128131
  • 54
    Mace JR, Keohan ML, Bernardy H et al. Crossover randomized comparison of intravenous versus intravenous/oral mesna in soft tissue sarcoma treated with high-dose ifosfamide. Clin Cancer Res 2003; 9: 58295834
  • 55
    Khojasteh NH, Zakerinia M, Ramzi M, Haghshenas M. A new regimen of MESNA (2-mercaptoethanesulfonate) effectively prevents cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplant recipients. Transplant Proc 2000; 32: 596
  • 56
    Frustaci S, Foladore S, De Pascale A et al. Feasibility and efficacy of arginine 2-mercaptoethanesulfonate (ARGIMESNA) in the prevention of hemorragic cystitis from ifosfamide (IFO). Ann Oncol 1992; 3 (Suppl. 2): S115118
  • 57
    Letendre L, Hoagland HC, Gertz MA. Hemorrhagic cystitis complicating bone marrow transplantation. Mayo Clin Proc 1992; 67: 128130
  • 58
    Ippoliti C, Przepiorka D, Mehra R et al. Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation. Urology 1995; 46: 811815
  • 59
    Hazewinkel MH, Stalpers LJ, Dijkgraaf MG et al. Prophylactic vesical instillations with 0.2% chondroitin sulfate may reduce symptoms of acute radiation cystitis in patients undergoing radiotherapy for gynecological malignancies. Int Urogynecol J 2011; 226: 725730
  • 60
    Shao Y, Lu GL, Shen ZJ. Comparison of intravesical hyaluronic acid instillation and hyperbaric oxygen in the treatment of radiation-induced hemorrhagic cystitis. BJU Int 2012; 109: 691694
  • 61
    Sommariva ML, Sandri SD, Ceriani V. Efficacy of sodium hyaluronate in the management of chemical and radiation cystitis. Minerva Urol Nefrol 2010; 62: 145150
  • 62
    Delgado JM, Samper P, Garrido J. Hyaluronic acid in the prevention of radiation-induced cystitis (Abstr.). Proc Am Soc Clin Oncol 2003; 22: 752
  • 63
    Samper Ots PM, López Carrizosa C, Rodríguez A et al. Vesical instillations of hyaluronic acid to reduce the acute vesical toxicity caused by high-dose brachytherapy do not affect the survival: a five-year follow-up study. Clin Transl Oncol 2009; 11: 828834
  • 64
    Levine LA, Jarrard DF. Treatment of cyclophosphamide-induced hemorrhagic cystitis with intravesical carboprost tromethamine. J Urol 1993; 149: 719723
  • 65
    Lojanapiwat B, Sripralakrit S, Soonthornphan S, Wudhikarn S. Intravesicle formalin instillation with a modified technique for controlling haemorrhage secondary to radiation cystitis. Asian J Surg 2002; 25: 232235
  • 66
    Dewan AK, Mohan GM, Ravi R. Intravesical formalin for hemorrhagic cystitis following irradiation of cancer of the cervix. Int J Gynaecol Obstet 1993; 42: 131135
  • 67
    Vicente J, Rios G, Caffaratti J. Intravesical formalin for the treatment of massive hemorrhagic cystitis: retrospective review of 25 cases. Eur Urol 1990; 18: 204206
  • 68
    Ho CC, Md Zainuddin Z. Alum irrigation for the treatment of intractable haematuria. Malays J Med Sci 2009; 16: 6668
  • 69
    Nordling J, van Ophoven A. Intravesical glycosaminoglycan replenishment with chondroitin sulphate in chronic forms of cystitis. A multi-national, multi-centre, prospective observational clinical trial. Arzneimittelforschung 2008; 58: 328335
  • 70
    Kallestrup EB, Jorgensen SS, Nordling J, Hald T. Treatment of interstitial cystitis with Cystistat: a hyaluronic acid product. Scand J Urol Nephrol 2005; 39: 143147
  • 71
    Morales A, Emerson L, Nickel JC. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. Urology 1997; 49 (Suppl.):111113
  • 72
    Diamantopoulos J, Kapsalis Z, Pliotas G et al. Use of sodium hyaluronate solution in patients suffering from post-radiation cystitis. ESTRO 2004
  • 73
    Gonzalez Patino E, Salvador Garrido N, Cascallar Caneda L et al. Protective effect on the urinary bladder mucosa of intravesical hyaluronic acid in cervix cancer patients treated with pelvic radiotherapy, weekly chemotherapy and high-dose rate brachytherapy. Presented at 2008 World Congress of Brachytherapy
  • 74
    Mañas A, Glaría L, Peña C et al. Prevention of urinary tract infections in palliative radiation for vertebral metastasis and spinal compression: a pilot study in 71 patients. Int J Radiat Oncol Biol Phys 2006; 64: 935940
  • 75
    Demir HA, Savaş Şen Z, Emir S, Tunç B. Successful treatment of cyclophosphamide-induced haemorrhagic cystitis with intravesical prostaglandin E1 in a child with non-Hodgkin's lymphoma. Scand J Urol Nephrol 2011; 45: 281284
  • 76
    Miura M, Sasagawa I, Kubota Y, Iijima Y, Sawamura T, Nakada T. Effective hyperbaric oxygenation with prostaglandin E1 for radiation cystitis and colitis after pelvic radiotherapy. Int Urol Nephrol 1996; 28: 643647
  • 77
    Yamamoto M, Hibi H, Ohmura M, Miyake K. Successful treatment of hemorrhagic cystitis secondary to cyclophosphamide chemotherapy with intravesical instillation of prostaglandin F2 alpha. Hinyokika Kiyo 1994; 40: 833835
  • 78
    Hemal AK, Praveen BV, Sankaranarayanan A, Vaidyanathan S. Control of persistent vesical bleeding due to radiation cystitis by intravesical application of 15 (S) 15-methyl prostaglandin F2-alpha. Indian J Cancer 1989; 26: 99101
  • 79
    Ostroff EB, Chenault OW Jr. Alum irrigation for the control of massive bladder hemorrhage. J Urol 1982; 128: 929930
  • 80
    Efros MD, Ahmed T, Coombe N, Choudhury MS. Urologic complications of high-dose chemotherapy and bone marrow transplantation. Urology 1994; 43: 355360
  • 81
    Arrizabalaga M, Extramiana J, Parra JL, Ramos C, Díaz González R, Leiva O. Treatment of massive haematuria with aluminium salts. Br J Urol 1987; 60: 223226
  • 82
    Bogris SL, Johal NS, Hussein I, Duffy PG, Mushtaq I. Is it safe to use aluminum in the treatment of pediatric hemorrhagic cystitis? A case discussion of aluminum intoxication and review of the literature. J Pediatr Hematol Oncol 2009; 31: 285288
  • 83
    Kanwar VS, Jenkins JJ 3rd, Mandrell BN, Furman WL. Aluminum toxicity following intravesical alum irrigation for hemorrhagic cystitis. Med Pediatr Oncol 1996; 27: 6467
  • 84
    Seear MD, Dimmick JE, Rogers PC. Acute aluminum toxicity after continuous intravesical alum irrigation for hemorrhagic cystitis. Urology 1990; 36: 353354
  • 85
    Nakada T, Nakada H, Yoshida Y et al. Hyperbaric oxygen therapy for radiation cystitis in patients with prostate cancer: a long-term follow-up study. Urol Int 2012; 89: 208214
  • 86
    Oliai C, Fisher B, Jani A et al. Hyperbaric oxygen therapy for radiation-induced cystitis and proctitis. Int J Radiat Oncol Biol Phys 2012; 84: 733740
  • 87
    Davis M, MacDonald H, Sames C, Nand K. Severe cyclophosphamide-induced haemorrhagic cystitis treated with hyperbaric oxygen. N Z Med J 2011; 124: 4854
  • 88
    Ajith Kumar S, Prasanth P, Tripathi K, Ghosh P. Hyperbaric oxygen-A new horizon in treating cyclophosphamide-induced hemorrhagic cystitis. Indian J Urol 2011; 27: 272273
  • 89
    Mohamad Al-Ali B, Trummer H, Shamloul R, Zigeuner R, Pummer K. Is treatment of hemorrhagic radiation cystitis with hyperbaric oxygen effective? Urol Int 2010; 84: 467470
  • 90
    Heath JA, Mishra S, Mitchell S, Waters KD, Tiedemann K. Estrogen as treatment of hemorrhagic cystitis in children and adolescents undergoing bone marrow transplantation. Bone Marrow Transplant 2006; 37: 523526
  • 91
    Ordemann R, Naumann R, Geissler G, Bornhauser M, Schuler U, Ehninger G. Encouraging results in the treatment of haemorrhagic cystitis with estrogen – report of 10 cases and review of the literature. Bone Marrow Transplant 2000; 25: 981985
  • 92
    Ashrani AA, Gabriel DA, Gajewski JL, Jacobs DR Jr, Weisdorf DJ, Key NS. Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy. Bone Marrow Transplant 2006; 38: 825828
  • 93
    Neheman A, Nativ O, Moskovitz B, Melamed Y, Stein A. Hyperbaric oxygen therapy for radiation-induced haemorrhagic cystitis. BJU Int 2005; 96: 107109
  • 94
    Chong KT, Hampson NB, Corman JM. Early hyperbaric oxygen therapy improves outcome for radiation-induced hemorrhagic cystitis. Urology 2005; 65: 649653
  • 95
    Bevers RF, Bakker DJ, Kurth KH. Hyperbaric oxygen treatment for haemorrhagic radiation cystitis. Lancet 1995; 346: 803805
  • 96
    Bui QC, Lieber M, Withers HR, Corson K, van Rijnsoever M, Elsaleh H. The efficacy of hyperbaric oxygen therapy in the treatment of radiation-induced late side effects. Int J Radiat Oncol Biol Phys 2004; 60: 871878
  • 97
    Corman JM, McClure D, Pritchett R, Kozlowski P, Hampson NB. Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen. J Urol 2003; 169: 22002202
  • 98
    Kalayoğlu-Beşişik S, Abdul-Rahman IS, Erer B et al. Outcome after hyperbaric oxygen treatment for cyclophosphamide-induced refractory hemorrhagic cystitis. J Urol 2003; 170: 922
  • 99
    Jou YC, Lien FC, Cheng MC, Shen CH, Lin CT, Chen PC. Hyperbaric oxygen therapy for cyclophosphamide-induced intractable refractory hemorrhagic cystitis in a systemic lupus erythematosus patient. J Chin Med Assoc 2008; 71: 218220
  • 100
    Kuroda I, Kuwata Y, Kakehi Y. Hyperbaric oxygen therapy for Wegener's granulomatosis with cyclophosphamide-induced hemorrhagic cystitis. Int J Urol 2002; 9: 470472
  • 101
    Miller J, Burfield GD, Moretti KL. Oral conjugated estrogen therapy for treatment of hemorrhagic cystitis. J Urol 1994; 151: 13481350
  • 102
    Liu YK, Harty JI, Steinbock GS, Holt HA Jr, Goldstein DH, Amin M. Treatment of radiation or cyclophosphamide induced hemorrhagic cystitis using conjugated estrogen. J Urol 1990; 144: 4143
  • 103
    Duthie G, Whyte L, Chandran H, Lawson S, Velangi M, McCarthy L. Introduction of sodium pentosan polysulfate and avoidance of urethral catheterisation: improved outcomes in children with haemorrhagic cystitis post stem cell transplant/chemotherapy. J Pediatr Surg 2012; 47: 375379
  • 104
    Toren PJ, Norman RW. Cyclophosphamide induced hemorrhagic cystitis successfully treated with pentosanpolysulphate. J Urol 2005; 173: 103
  • 105
    Hampson SJ, Woodhouse CR. Sodium pentosanpolysulphate in the management of haemorrhagic cystitis: experience with 14 patients. Eur Urol 1994; 25: 4042
  • 106
    Karimi M, Zakerinia M, Khojasteh HN, Ramzi M, Ahmad E. Successful treatment of cyclophosphamide induced intractable hemorrhagic cystitis with recombinant FVIIa (NovoSeven) after allogenic bone marrow transplantation. J Thromb Haemost 2004; 2: 18531855
  • 107
    Geisler JP, Linnemeier GC, Manahan KJ. Recombinant factor VIIa to treat late radiation-induced hemorrhagic cystitis: a case report. J Reprod Med 2008; 53: 360362
  • 108
    Connolly SS, D'Arcy FT, Corcoran MO. Recombinant activated factor VII to control life-threatening haemorrhagic radiation cystitis. Ir J Med Sci 2010; 179: 431433
  • 109
    Demesmay K, Tissot E, Bulabois CE et al. Factor XIII replacement in stem-cell transplant recipients with severe hemorrhagic cystitis: a report of four cases. Transplantation 2002; 74: 11901192
  • 110
    Pihusch M, Bacigalupo A, Szer J et al. Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation. J Thromb Haemost 2005; 3: 19351944
  • 111
    Singh I, Laungani GB. Intravesical epsilon aminocaproic acid in management of intractable bladder haemorrhage. Urology 1992; 40: 227229
  • 112
    Wang CH, Fang CC, Chen NC et al. Cranberry-containing products for prevention of urinary tract infections in susceptible populations: a systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 2012; 172: 988996
  • 113
    Bonetta A, Di Pierro F. Enteric-coated, highly standardized cranberry extract reduces risk of UTIs and urinary symptoms during radiotherapy for prostate carcinoma. Cancer Manag Res 2012; 4: 281286
  • 114
    Cowan CC, Hutchison C, Cole T et al. A randomized double-blind placebo-controlled trial to determine the effect of cranberry juice on decreasing the incidence of urinary symptoms and urinary tract infections in patients undergoing radiotherapy for cancer of the bladder or cervix. Clin Oncol (R Coll Radiol) 2012; 24: e3138
  • 115
    Campbell G, Pickles T, D'Yachova Y. A randomised trial of cranberry versus apple juice in the management of urinary symptoms during external beam radiation therapy for prostate cancer. Clin Oncol (R Coll Radiol) 2003; 15: 322328
  • 116
    Chuang YC, Kim DK, Chiang PH, Chancellor MB. Bladder botulinum toxin A injection can benefit patients with radiation and chemical cystitis. BJU Int 2008; 102: 704706
  • 117
    Vela-Ojeda J, Tripp-Villanueva F, Sanchez-Cortés E et al. Intravesical rhGM-CSF for the treatment of late onset hemorrhagic cystitis after bone marrow transplant. Bone Marrow Transplant 1999; 24: 13071310
  • 118
    Gweon P, Shanberg A. Treatment of cyclophosphamide induced hemorrhagic cystitis with neodymium:YAG laser in pediatric patients. J Urol 1997; 157: 23012302
  • 119
    Ravi R. Endoscopic neodymium:YAG laser treatment of radiation-induced hemorrhagic cystitis. Lasers Surg Med 1994; 14: 8387
  • 120
    Veerasarn V, Boonnuch W, Kakanaporn C. A phase II study to evaluate WF10 in patients with late hemorrhagic radiation cystitis and proctitis. Gynecol Oncol 2006; 100: 179184
  • 121
    Pomer S, Karcher G, Simon W. Cutaneous ureterostomy as last resort treatment of intractable haemorrhagic cystitis following radiation. Br J Urol 1983; 55: 392394
  • 122
    Pillay PK, Teh M, Chua EJ, Tan EC, Tung KH, Foo KT. Haemorrhagic chronic radiation cystitis – following treatment of pelvic malignancies. Ann Acad Med Singapore 1984; 13: 634638
  • 123
    Giné E, Rovira M, Real I et al. Successful treatment of severe hemorrhagic cystitis after hemopoietic cell transplantation by selective embolization of the vesical arteries. Bone Marrow Transplant 2003; 31: 923925
  • 124
    Palandri F, Bonifazi F, Rossi C et al. Successful treatment of severe hemorrhagic cystitis with selective vesical artery embolization. Bone Marrow Transplant 2005; 35: 529530
  • 125
    Cho CL, Lai MH, So HS, Kwok KK, Chan JC, Velayudhan V. Superselective embolisation of bilateral superior vesical arteries for management of haemorrhagic cystitis. Hong Kong Med J 2008; 14: 485488
  • 126
    Perez-Mendoza R, Martinez P, Solares M, Badillo M, Gallo M, Jiménez-Rios MA. Management of post-radiotherapy hemorrhagic cystitis refractory to conventional treatment. BMC Cancer 2007; 7 (Suppl. 1): A44
  • 127
    Harkensee C, Vasdev N, Gennery AR, Willetts IE, Taylor C. Prevention and management of BK-virus associated haemorrhagic cystitis in children following haematopoietic stem cell transplantation – a systematic review and evidence-based guidance for clinical management. Br J Haematol 2008; 142: 717731
  • 128
    Ribeiro RA, Lima-Junior RCP, Leite CA et al. Chemotherapy-induced hemorrhagic cystitis: pathogenesis, pharmacological approaches and new insights. J Exp Integr Med 2012; 2: 95112
  • 129 Identifier. NCT01659723. Available at: Accessed September 2012
  • 130
    Madersbacher H, van Ophoven A, van Kerrebroeck PE. GAG layer replenishment therapy for chronic forms of cystitis with intravesical glycosaminoglycans – a review. Neurourol Urodyn 2012; 32: 918
  • 131
    Yin Y, Liao B, Gao Q, Song T, Liu GJ, Wu H. Interventions for preventing hemorrhagic cystitis in patients undergoing hematopoietic stem cell transplantation. Cochrane Database Syst Rev 2011; (8)CD009212